Smith & Nephew (SNNUF) Capital Expenditures (2009 - 2024)
Smith & Nephew (SNNUF) reported Capital Expenditures of -$172.0 million for Q4 2024, down 2.99% on a YoY basis from -$177.3 million in Q1 2024, and down 2.99% quarter-over-quarter from -$167.0 million in Q4 2023.
Smith & Nephew (SNNUF) Capital Expenditures (2009 - 2024) Analysis & Trends
Smith & Nephew has reported Capital Expenditures for 16 years, with the latest figure at -$172.0 million in Q4 2024.
- For the quarter ending Q4 2024, Capital Expenditures fell 2.99% year-over-year to -$172.0 million; the trailing twelve-month figure through Dec 2024 stood at -$687.0 million (up 2.28% YoY), and the FY2025 full-year result was $433.0 million, up 13.65% from the prior year.
- Capital Expenditures for Q4 2024 stood at -$172.0 million, down from -$167.0 million in the prior quarter.
- The five-year high for Capital Expenditures was -$167.0 million in Q4 2023, with the low at -$188.0 million in Q4 2020.
- Historically, Capital Expenditures has averaged -$175.0 million across 5 years, with a median of -$173.0 million in 2022.
- Annual changes were most pronounced in 2020 — Capital Expenditures soared 53.92% — and 2024, when it retreated 2.99%.
- Smith & Nephew's Capital Expenditures stood at -$188.0 million in 2020, then rose by 6.91% to -$175.0 million in 2021, then grew by 1.14% to -$173.0 million in 2022, then climbed by 3.47% to -$167.0 million in 2023, then retreated by 2.99% to -$172.0 million in 2024.
- The last three Capital Expenditures figures came in at -$172.0 million (Q4 2024), -$167.0 million (Q4 2023), and -$173.0 million (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 444.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -85.46 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 76.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 86.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 90.20 Mn |
| 10 | Smith & Nephew | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -172.00 Mn |
| Dec 31, 2024 | -172.00 Mn |
| Dec 31, 2023 | -167.00 Mn |
| Dec 31, 2023 | -167.00 Mn |
| Dec 31, 2022 | -173.00 Mn |
| Dec 31, 2022 | -173.00 Mn |
| Dec 31, 2021 | -175.00 Mn |
| Dec 31, 2021 | -175.00 Mn |
| Dec 31, 2020 | -188.00 Mn |
| Dec 31, 2020 | -188.00 Mn |
| Dec 31, 2019 | -408.00 Mn |
| Dec 31, 2019 | -408.00 Mn |
| Dec 31, 2018 | -347.00 Mn |
| Dec 31, 2018 | -347.00 Mn |
| Dec 31, 2017 | -376.00 Mn |
| Dec 31, 2017 | -376.00 Mn |
| Dec 31, 2016 | -392.00 Mn |
| Dec 31, 2016 | -392.00 Mn |
| Dec 31, 2015 | -358.00 Mn |
| Dec 31, 2015 | -358.00 Mn |